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mellitus among patients with stroke in the Arab
world.
Methods: We searched published literature to identify
studies reporting on patients with stroke from the Arab
countries. Eligible articles were reviewed to extract data
on the frequency of diabetes among their samples and on
the details of disease diagnostic criteria, control status
and stroke subtypes.
Results: We identified 29 studies reporting on a total
of 10,242 patients. The estimated prevalence of dia-
betes among the ischaemic stroke population of these
studies was 37.5%. None of the studies described the
prevalence of diabetes among haemorrhagic patients
with stroke. The criteria for diagnosing diabetes were
not always described. Studies from the Gulf countries
tended to report a higher prevalence of diabetes
mellitus than studies from other Arab-world
countries.
Conclusions: There is insufficient reporting regarding
the status of diabetes mellitus and its complications.
The majority of studies suggest a remarkable vari-
ability in its prevalence. We hope that this review
will draw attention to this prevalent health problem
and prompt a better estimation of the impact of
diabetes mellitus on the vascular health of our
nations.
Keywords: Diabetes mellitus; Prevalence; Stroke; The Arab
world; Vascular health
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S.A. Rammal and M.A. Almekhlafi296IntroductionDiabetes mellitus is a prominent global health issue and is
a leading cause of morbidity and mortality worldwide.1
According to the United Kingdom National Health
Services (UK NHS), 3.9 million people are living with
diabetes, a number that has doubled since 1996, when 1.4
million people had the disease. It is estimated that, by
2025, five million people will have diabetes in the UK.2
Estimates of the prevalence of the disease in the Arab
world are even higher. A recent WHO report from the
Eastern Mediterranean region estimated the prevalence of
diabetes to be between 3.5% and 30%. Bahrain, Kuwait,
Lebanon, Oman, KSA and the United Arab Emirates
report the highest prevalence of diabetes in this region.1 In
the United Arab Emirates, a survey of 2455 adults
concluded that the prevalence of diabetes was about
10.2%.3 In a study published in 2015 from Riyadh, KSA,
the reported prevalence of Type 2 diabetes among 2355
adults was 29.3%.4
Diabetes accounts for a large proportion of mortality
worldwide. The World Health Organization estimates that,
in 2012, 1.5 million people died from diabetes, making up 4%
of the total deaths from non-communicable diseases. This
morbidity is related to the multiple vital organs that are
negatively impacted by the disease. Diabetic vasculopathy
can affect micro or macrovascular circulation, leading to
coronary, cerebrovascular and peripheral vascular diseases
with dire consequences.5
Stroke can be broadly classified as ischaemic or haemor-
rhagic. About 85% of strokes are ischaemic, resulting from a
blocked brain artery and leading to permanent damage and
loss of function. Haemorrhagic stroke (15% of strokes) re-
sults from blood escaping a brain artery into the adjacent
brain tissue, producing permanent damage there. Haemor-
rhagic strokes usually cause more damage than ischaemic
strokes. There are modifiable and non-modifiable risk factors
of ischaemic strokes. Age, family history of stroke, and sex
are among the non-modifiable risks; modifiable factors
include diabetes, hypertension, elevated cholesterol, cardiac
disease and smoking.
Diabetes mellitus is frequently encountered as a risk fac-
tor among patients with stroke. Estimates suggest that pa-
tients with diabetes have twice the risk of stroke compared to
non-diabetics.6 The incidence of ischaemic stroke was 2.5-
and 3.6-times greater higher among diabetic men and
women, respectively, in the Framingham study.7 In the
BaltimoreeWashington stroke study, stroke risk was 10-
times greater in diabetic patients younger than 44 years of
age.8 This strong association can be attributed to diabetes-
related atherosclerosis of the cervical and cerebral vessels,9
which increases the relative prevalence of subcortical
infarction and small- and large-vessel disease.10 In
addition, diabetes affects the cerebral microvasculature,
with negative implications for the structure and function of
the endothelial cells of the cerebral artery. Diabetes also
has a direct effect on cortical neurons.11
Compared with data from the West, the link between
diabetes and stroke in the Arab countries is not well-
described in the literature. Studies on strokes in the Arab
world have described the prevalence of diabetes as highlyvariable, ranging from 11.6% to 69.4% among patients with
stroke.12 In this review, we investigate the reported
prevalence of diabetes among patients with stroke in the
Arab world and contrast these figures with those reported
in western literature. We also explore the reasons for the
variability of these reports. This study will help advance
the understanding of any important stroke risk factors and
mechanisms unique to the Arab countries, which will
hopefully contribute positively to the management of
diabetic patients with stroke.
Materials and Methods
Search strategy
Articles published on diabetes and stroke in the Arab
countries were identified by searching Pub-med with the
keywords “cerebral infarction”, “ischaemia”, “stroke”, “ce-
rebrovascular diseases”, “diabetes” and “hyperglycemia” in
conjunction with “Arab countries”, “Arab”, “Middle East”
and the names of various Arabic countries. The search was
supplemented by identifying relevant reports in the published
articles as well as other sources from the Center for Disease
Control and theWHO. The full texts of relevant manuscripts
were retrieved for detailed assessment.
The selection criteria included the following:
Inclusion criteria:
1. Study conducted in the Arab countries on a geographical
basis.
2. Reported the prevalence, types, risk factors or outcomes
of strokes in diabetic patients.
3. All groups are older than 18 years.
Exclusion criteria:
1. Stroke studies did not report the prevalence of diabetes.
2. Studies exclusively reported on strokes among Type 1
diabetics due to the lower prevalence of this type of dia-
betes in comparison with Type 2.
3. Studies reported on strokes among women with gesta-
tional diabetes, as this is a different pathophysiological
entity.
Data extraction and analyses
We extracted from the selected articles important data
related to stroke prevalence, sex distribution, age, stroke
types, diabetes types, risk factor profile, the association be-
tween stroke and diabetes and outcomes. We specifically
searched for the definition of diabetes researchers used and
the frequency of diabetes among the various groups. When
feasible, the data were tabulated and analysed to produce the
weighted means and proportions of the relevant variables.
Results
Our search identified 29 articles that met our inclusion
criteria. These articles reported on a total of 10,242 patients.
Table 1 describes the characteristics of these studies, which
Diabetes mellitus and stroke 297came from KSA (7 studies),13e19 Qatar (5 studies),20e24
Kuwait (3 studies),25e27 Bahrain (2 studies),28,29 Libya (3
studies),30e32 Egypt (1 study),33 Jordan (2 studies),34,35
Palestine (2 studies),36,37 Sudan (1 study),38 Iraq (2
studies),39,40 and the United Arab Emirates (1 study).41
The articles were published between 1986 and 2015. Only
five studies included prospectively identified patients, while
the rest were either retrospective or cross-sectional. Fe-
males made up 39.2% of patients, whose mean age ranged
between 52 and 65 years.
Ischaemic stroke accounted for 82% of all patients in the
included studies, while haemorrhagic stroke made up 18%.
Stroke was diagnosed mainly based on Computerized To-
mography imaging (CT). Among ischaemic strokes, only one
study showed that diabetes was associated with lacunar-type
strokes (56%) in comparison to non-lacunars (43%).13 Non-
lacunar strokes had higher mortality rates in comparison
with lacunar strokes.26 Other studies15,26 reported death
from ischaemic strokes but presented no clear data on the
type of stroke. Others22 concluded that in-hospital mortal-
ity was higher in cases of haemorrhagic strokes (16%).
The prevalence of diabetes among the ischaemic stroke
population in these studies was 37.5% (Table 2). None of
the studies described the prevalence of diabetes among
patients with haemorrhagic strokes. None of the identified
studies described the criteria used to diagnose diabetes.
Ten studies (34.5%) reported that over half of their
patients were diabetics. All these studies were from GulfTable 1: Characteristics of the included studies’ design and methods.
Study Country Year of
publication
Study design
Ashok Libya 1986 Prospective
Yaqub KSA 1991 Retrospective
Al-Rajeh KSA 1993 Retrospective
Ahmad Libya 1995 Retrospective
Abdulghaffar Kuwait 1997 Prospective
Al-Rajeh KSA 1998 Retrospective
El-Sayed KSA 1999 Prospective
Al-Jishi Bahrain 2000 Retrospective
Qari KSA 2000 Retrospective
Hamad Qatar 2001 Retrospective
Hatem KSA 2001 Descriptive
Sokrab Sudan 2002 Prospective
McLachlan UAE 2002 NR
Al-Shammri Kuwait 2003 Retrospective
Al-Heeti Iraq 2003 Retrospective
Bahou Jordan 2004 Retrospective
Bener Qatar 2005 Retrospective
Al-Mahdawi Iraq 2005 Cross-sectiona
Deleu Qatar 2006 Retrospective
Khan Qatar 2008 Prospective
Sweileh Palestine 2008 Retrospective
Sawalha Palestine 2009 Retrospective
Awada KSA 2009 Retrospective
Ashkanani Kuwait 2012 Retrospective
Auais Jordan 2012 Case-control
Christos Qatar 2013 Case-control
Khedr Egypt 2014 Cross-sectiona
Al-Banna Kuwait 2015 Retrospective
Shambesh Libya 2015 Cross-sectiona
NR: Not reported.countries. At 78.5%, the greatest proportion of patients in
the studies was from Bahrain, as reported in the study by
Al-Jishi et al.28Discussion
Our study found a high prevalence of diabetes among
ischaemic patients with stroke in the Arab world, which re-
flects a major challenge and opportunity facing the health-
care authorities of these countries. Data on haemorrhagic
stroke in correlation with diabetes in the Arab literature is
deficient and needs to be better defined. These findings
emphasize the link between diabetes and cerebrovascular
disorders, which may justify the need for screening programs
to prevent such vascular complications. In addition, studying
the impact of glycaemic control on the timing and degree of
vascular complications would justify launching population-
wide campaigns for screening and treating diabetes.
There is a known association between diabetes and ce-
rebral artery abnormalities on the molecular and patho-
physiological levels. Helgason et al.42 described that diabetic
angiopathy involvement depends on the location and size of
the affected vessels. The large-, medium- and small-sized
vessels in cortical brain regions and other sites showed
atheromatous changes and lipid or hyalin transformation,
while capillaries showed diffuse focal thickening of base-
mene membrane. In addition, diabetes can cause directDuration of study Diagnostic criteria
in stroke/diabetes
1983e1984 NR
1984e1989 WHO/NR
& prospective 1982e1992 NR
1991e1993 NR
1989e1993 WHO/NR
1989e1993 NR
1994e1996 WHO/NR
1995 WHO/NR
1997e2000 WHO/NR
1997 NR
1996e1998 WHO/NR
NR NR
NR NR
1995e1999 WHO/NR
1993e1998 NR
2000e2002 WHO/NR
& prospective 1999e2003 NR
l 2002 NR
2001 NR
2004e2005 WHO/NR
2006e2007 NR
2006e2007 NR
& prospective 1982e1995 NR
2008 TOAST/NR
NR NR
2006e2008 NR
l 2011e2013 WHO/NR
NR NR
l 2010e2014 NR
Table 2: Characteristics of patients in the included studies.
Study Number Female (%) Mean age
male/female
Haemorrhagic
stroke %
Diabetes % % DM in ischaemic vs.
haemorrhagic strokes
Ashok 329 44.1% 69/58 19.1% 43% NR
Yaqub 200 NR NR 11% 24% 25% vs. 8%
Al-Rajeh 500 31.6% NR 23.8% 42% NR
Ahmad 921 43.3% 52/42 23.1% 23.1% NR
Abdulghaffar 241 57.7% 58.5/63 21.6% 42% NR
Al-Rajeh 488 35.7% NR 31% 37% NR
El-Sayed 329 49.5% 62.8/59.6 21% 11.6% NR
Al-Jishi 144 38.2% 45/65 24% 78.5% 63.6% vs. 14.5%
Qari 71 22.5% 63 16% 27% NR
Hamad 217 27.6% 57 20% 45.5% NR
Hatem 25 NR 61.2 None 72% NA
Sokrab 96 41.7% Median > 60 41.6% 14.6% NR
McLachlan 63 NR NR NR 55% NR
Al-Shammri 62 51.6% 64.1 None 69.4% NA
Al-Heeti 188 NR Median > 65 NR 25% NR
Bahou 200 44.0% 61.2 None 43.5% NA
Bener 377 NR NR None 46.4% NA
Al-Mahdawi 100 NR 63.5 None 28% NA
Deleu 303 NR NR None 51% NA
Khan 270 27.0% 57.1/61.3 19.6% 58.9% 66.8% vs. 26.4%
Sweileh 186 51.1% 69.1 17.7% 45.2%
Sawalha 153 45.8% 69.1 None 45.8% NA
Awada 1000 32.0% 59 24% 41% NR
Ashkanani 151 NR NR 9.9% 56.3% NR
Auais 200 60.0% Median < 60 None 50% NA
Christos 262 18.7% Median < 55 NR 52.1% NR
Khedr 148 37.8% 59.6 125 36.9% NR
Al-Banna 521 NR NR NR 54% NR
Shambesh 2908 45.9% Median > 60 NR 2908 NR
NR: Not reported. NA: Not applicable.
S.A. Rammal and M.A. Almekhlafi298neuronal injury through stress hyperglycaemia. This is
particularly relevant in an acute stroke setting where
hyperglycaemia enhances cortical intracellular acidosis,
which increases glutamate release, leading to cortical
depression and infarction of the ischaemic penumbral tissue
(the penumbra is the area around the core infarct that is
potentially salvageable).43
Clinical studies have linked hyperglycaemia with poor
stroke outcomes. A Cochrane review on this topic43
identified hyperglycaemia as an independent predictor for
higher stroke mortality.44 Across 7 trials, 1296 participants
were divided into a control group (657 patients) and
intervention group (639 patients), and treated with an
intravenous insulin infusion with or without subcutaneous
insulin at mealtime in the first hours of stroke presentation.
In the intervention group, the glucose target varied,
ranging from 70 to 110 mg/dL and 90e144 mg/dL, while
the control group received a placebo, no treatment or
subcutaneous insulin, with a loose glucose target of 70e
200 mg/dL. The subcutaneous insulin was given if glucose
levels exceeded 180e306 mg/dL. At 0.46, the mean
glycaemic level in the intervention group was significantly
lower compared to the control group. The authors
concluded that the intervention group displayed no
significant benefits in regards to mortality, functional
outcome or improvement in neurological deficits.
Moreover, the intervention increased the prevalence of
hypoglycaemic attacks among those patients.Despite the detrimental effects of hyperglycaemia on ce-
rebral tissue in the early phase of stroke onset, the rapid
lowering of elevated blood glucose in the first 24 h following
stroke onset via rapidly acting insulin is not supported. In a
systematic review of 33 studies, Capes et al.45 concluded that
stress hyperglycaemia (defined as at least fasting blood
glucose >6.1 and random >6) during acute stroke
presentation is associated with worse clinical outcomes.
However, there was no significant association with
mortality in the short-term or functional recovery for up to
6months after a stroke compared to non-diabetics with stress
hyperglycaemia at presentation. The UKPDS46 randomized
controlled trial studied the impact of tight diabetes control
on future stroke risk among 3867 Type 2 diabetics who
were randomized to receive sulphonylurea or insulin in
comparison with a conventional diet-controlled group. The
groups that received intensive blood glucose therapy had no
significant reduction of stroke risk during 10.7 years of
follow-up. However, stroke risk is higher among diabetics
regardless of the level of metabolic control.47
Our review of the literature on diabetes in the Arab world
identified a number of areas that require further research.
With the high prevalence of diabetes in our countries, large
prospective registries that capture the full spectrum of dia-
betes complications, including stroke, are needed. These
registries will accurately estimate the impact of diabetes on
the vascular health of the population and will help identify its
possible interactions with factors such as age, ethnicity, other
Diabetes mellitus and stroke 299co-morbidities and stroke subtypes. The existing studies lack
sufficient information on important aspects of the clinical
profile of the enrolled patients, including the duration of
diabetes, blood glucose control status, the treatment used
and the relationship with other relevant diabetes complica-
tions. Given their high prevalence of diabetes, the Arab
countries could also take the lead on potential areas of future
studies, including the involvement of microvascular circula-
tions, such as intracranial and retinal circulations, in diabetic
patients. Such studies would provide more insights onto the
pathogenic mechanisms and can stimulate the development
of medications that will hopefully halt the disease’s effect on
diabetics’ vasculature.
Conclusions
In this review of the literature examining the relationship
between diabetes and stroke in the Arab countries, we
identified deficiencies in the reporting on diabetes in the
majority of studies and significant variability in conclusions
regarding the disease’s prevalence. We hope that the present
study will draw attention to this widespread health problem
to estimate the impact of stroke and diabetes on the vascular
health of our nations more accurately.
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